Sylvie Fraitag Selected Research

Systemic Scleroderma (Systemic Sclerosis)

10/2021

Enhanced cGAS-STING-dependent interferon signaling associated with mutations in ATAD3A.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sylvie Fraitag Research Topics

Disease

12	Neoplasms (Cancer) 12/2022 - 12/2008
4	Nevus (Nevi) 01/2019 - 08/2012
3	Mastocytosis 04/2024 - 08/2015
3	Infections 01/2022 - 07/2015
3	Melanoma (Melanoma, Malignant) 10/2021 - 11/2016
3	Langerhans-Cell Histiocytosis (Histiocytosis, Langerhans Cell) 03/2021 - 01/2016
3	Myofibromatosis 01/2021 - 07/2017
3	Panniculitis 06/2018 - 08/2013
3	Fever (Fevers) 01/2018 - 08/2011
3	Exanthema (Rash) 11/2017 - 08/2011
2	Systemic Mastocytosis 04/2024 - 11/2017
2	Mitochondrial Diseases (Mitochondrial Disease) 11/2023 - 10/2021
2	Granuloma 01/2022 - 10/2011
2	Folliculitis (Sycosis) 03/2021 - 01/2018
2	Myofibroma 01/2021 - 08/2019
2	Tuberous Sclerosis (Bourneville's Disease) 01/2021 - 04/2012
2	Subcutaneous panniculitis-like T-cell lymphoma 12/2018 - 03/2017
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 12/2018 - 02/2010
2	Inflammation (Inflammations) 10/2017 - 11/2014
2	Thrombocytopenia (Thrombopenia) 08/2015 - 07/2010
2	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 01/2013 - 06/2004
2	Netherton Syndrome 09/2011 - 07/2006
2	Skin Diseases (Skin Disease) 02/2010 - 11/2009
2	Lymphoma (Lymphomas) 12/2008 - 11/2002
1	Hypertrophy 11/2023
1	Hypoglycemia (Reactive Hypoglycemia) 11/2023
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2023
1	Bacteremia 01/2023
1	Cellulitis 01/2023
1	Measles 01/2022
1	Inborn Genetic Diseases (Disease, Hereditary) 01/2022
1	Chickenpox 01/2022
1	Kaposiform Hemangioendothelioma 01/2022
1	Mumps 01/2022
1	Mucositis 10/2021
1	Diarrhea 10/2021
1	Systemic Scleroderma (Systemic Sclerosis) 10/2021
1	Bites and Stings (Sting) 10/2021
1	Skin Neoplasms (Skin Cancer) 10/2021
1	Hypopigmentation (Hypomelanosis) 01/2021
1	Urticaria Pigmentosa 01/2021
1	Cutaneous Mastocytosis 01/2021
1	Pigmented Nevus (Melanocytic Nevus) 01/2019
1	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 12/2018
1	Fasciitis (Fascitis) 06/2018
1	Tinea (Ringworm) 02/2018
1	Reinfection 01/2018
1	Long Term Adverse Effects 12/2017
1	Asthenia 11/2017
1	Synovitis 10/2017
1	Contracture 10/2017
1	Basal Cell Carcinoma (Rodent Ulcer) 10/2017

Drug/Important Bio-Agent (IBA)

2	AlpelisibIBA 11/2023 - 10/2021
2	LipidsIBA 12/2022 - 03/2021
2	Proteins (Proteins, Gene)FDA Link 12/2022 - 10/2013
2	Sirolimus (Rapamycin)FDA Link 01/2022 - 08/2015
2	Phosphotransferases (Kinase)IBA 01/2022 - 11/2017
2	Adrenal Cortex Hormones (Corticosteroids)IBA 03/2021 - 12/2017
2	RNA (Ribonucleic Acid)IBA 01/2021 - 01/2019
2	Platelet-Derived Growth Factor beta Receptor (Receptor, Platelet Derived Growth Factor beta)IBA 08/2019 - 07/2017
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2019 - 01/2017
2	AutoantibodiesIBA 01/2018 - 10/2017
2	Acute-Phase Proteins (Acute-Phase Protein)IBA 01/2018 - 10/2017
2	SteroidsIBA 10/2017 - 11/2012
2	C-Reactive ProteinIBA 07/2015 - 08/2011
2	CytokinesIBA 11/2014 - 08/2011
2	Cadherins (E-Cadherin)IBA 02/2010 - 07/2006
2	Matrix Metalloproteinases (MMPs)IBA 07/2006 - 08/2003
1	TOR Serine-Threonine KinasesIBA 04/2024
1	Insulin (Novolin)FDA Link 11/2023
1	ibrutinibIBA 01/2023
1	ras-GRF1 (ras GRF1)IBA 01/2022
1	Rubella VaccineIBA 01/2022
1	Attenuated VaccinesIBA 01/2022
1	VaccinesIBA 01/2022
1	Guanine Nucleotide Exchange Factors (Guanine Nucleotide Exchange Factor)IBA 01/2022
1	Mitochondrial DNA (mtDNA)IBA 10/2021
1	cyclic guanosine monophosphate-adenosine monophosphateIBA 10/2021
1	InterferonsIBA 10/2021
1	Biomarkers (Surrogate Marker)IBA 10/2021
1	Imiquimod (Aldara)FDA LinkGeneric 03/2021
1	TabletsIBA 01/2021
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2021
1	Imatinib Mesylate (Gleevec)FDA Link 01/2021
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 08/2019
1	Immunoglobulins (Immunoglobulin)IBA 12/2018
1	Mucin-3IBA 12/2018
1	MucinsIBA 06/2018
1	Palmitic Acid (Hexadecanoic Acid)IBA 01/2018
1	masitinibIBA 11/2017
1	Methotrexate (Mexate)FDA LinkGeneric 10/2017
1	Enhancer RNAsIBA 10/2017

Therapy/Procedure

10	Therapeutics 01/2023 - 02/2011
2	Drug Therapy (Chemotherapy) 01/2021 - 12/2017
2	Transplantation 02/2018 - 10/2016
2	Stem Cell Transplantation 01/2013 - 06/2004
2	Injections 10/2011 - 02/2010
1	Neoadjuvant Therapy 01/2019
1	Operative Surgical Procedures 01/2019
1	Radiotherapy 12/2017